Tallenna
Antibody Expression and Production
Engineered antibodies currently represent over 30% of biopharmaceuticals in clinical trials and their total worldwide sales continue to increase significantly. There is a strong focus on those issues related to the production of intrabodies, bispecific antibody and antibody fragments and also to novel applications in cancer immunotherapy.
- Toimittaja
- Mohamed Al-Rubeai
- Painos
- 2011 ed.
- ISBN
- 9789400736139
- Kieli
- englanti
- Paino
- 310 grammaa
- Julkaisupäivä
- 15.7.2013
- Kustantaja
- Springer
- Sivumäärä
- 346
